Skip to content
★ Sign in to follow
AS

Angelo Scopelianos

Directeur de la R&D
Total declarations
32
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€57k

Latest filing published 25 Mar 2024 for Axogen, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
4

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Angelo Scopelianos: trading record in brief

Angelo Scopelianos, listed as senior executive, appears in our data through filings on Axogen, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 18 February 2020 to 21 March 2024, the count stands at 32 filings.

No open-market purchase appears, only 4 sales worth €57k. The rest of the record consists of 17 share grants and 9 option exercises. In 2024 alone, the filings show no purchases and 3 sales.

The record was last updated on 25 March 2024 with an option exercise in Axogen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Angelo Scopelianos

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations